IridescentBio is the platform for decision making in antibody R&D
IridescentBio has raised $378K in total funding. The most recent round was Seed. The last funding was announced in December 2023.
IridescentBio's investors include UNIIQ.
IridescentBio is headquartered in Leiden, The Netherlands.
IridescentBio is the platform for decision making in antibody R&D
IridescentBio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"IridescentBio — Funding & Investors." VCBacked, December 5, 2023, https://www.vcbacked.co/company/iridescentbio. Accessed August 1, 2026.
VCBacked. (2023). IridescentBio — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/iridescentbio
{{cite web |title=IridescentBio — Funding & Investors |url=https://www.vcbacked.co/company/iridescentbio |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated